Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in genomics and transcriptomics
3.2.1.2 Increasing demand for mRNA vaccines and therapeutics
3.2.1.3 Research and development in molecular biology
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited accessibility and affordability
3.2.2.2 Stringent regulatory challenges
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 DNA templates
5.3 RNA templates
5.4 Templates and transcription kits
5.5 Other product types
Chapter 6 Market Estimates and Forecast, By Disease, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Cancer
6.2.1 Lung cancer
6.2.2 Breast cancer
6.2.3 Colorectal cancer
6.2.4 Prostate cancer
6.2.5 Leukemia
6.2.6 Ovarian cancer
6.2.7 Other cancers
6.3 Infectious disease
6.3.1 Influenza
6.3.2 Ebola virus
6.3.3 Hepatitis C virus
6.3.4 Human immunodeficiency virus (HIV)
6.3.5 Dengue virus
6.3.6 Other infectious diseases
6.4 Lifestyle disease
6.5 Genetic disease
6.6 Other diseases
Chapter 7 Market Estimates and Forecast, By Treatment, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Vaccine
7.3 Therapeutic
Chapter 8 Market Estimates and Forecast, By Research Stage, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Exploratory
8.3 Clinical
Chapter 9 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Biotechnology and pharmaceutical companies
9.3 Academic and research institutes
9.4 Contract research organizations
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Agilent Technologies Inc.
11.2 Bio-Synthesis Inc.
11.3 Bio-Rad Laboratories Inc.
11.4 CINVEN LIMITED
11.5 Danaher Corporation
11.6 Enzynomics Co Ltd.
11.7 Enzo Biochem Inc.
11.8 F. Hoffmann-La Roche Ltd.
11.9 Illumina Inc.
11.10 LGC Limited
11.11 Merck KGaA
11.12 Promega Corporation
11.13 Qiagen N.V.
11.14 Takara Bio Inc.
11.15 Thermo Fisher Scientific Inc.
